Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Net Income: 2009-2025

Historic Net Income for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$38.7 million.

  • Lifecore Biomedical's Net Income fell 38333.33% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 1543.59%. This contributed to the annual value of -$38.7 million for FY2025, which is 1543.59% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Net Income of -$38.7 million as of FY2025, which was down 1,543.59% from $2.7 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Net Income registered a high of $2.7 million during FY2024, and its lowest value of -$101.9 million during FY2022.
  • Its 3-year average for Net Income is -$23.8 million, with a median of -$35.3 million in 2023.
  • In the last 5 years, Lifecore Biomedical's Net Income skyrocketed by 107.59% in 2024 and then tumbled by 1,543.59% in 2025.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Net Income stood at -$10.3 million in 2021, then crashed by 890.66% to -$101.9 million in 2022, then surged by 65.34% to -$35.3 million in 2023, then soared by 107.59% to $2.7 million in 2024, then tumbled by 1,543.59% to -$38.7 million in 2025.